Randomised Study to Assess the Efficacy and Safety of Once-Daily Etravirine-Based Regimen as a Switching Strategy in HIV-Infected Patients Receiving a Protease Inhibitor-Containing Regimen. Etraswitch Study
Abstract
- Publication:
-
PLoS ONE
- Pub Date:
- February 2014
- DOI:
- 10.1371/journal.pone.0084676
- Bibcode:
- 2014PLoSO...984676E